Table 2 Pathologic features of ILCEM.
Pathologic features | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Primary tumor sizea (cm) | Multifocal | Number of positive nodes | Nottingham gradeb | Score of tubule formation | Score of nuclear grade | Score of mitotic activity | Presence of LCIS | Presence of necrosis | ER status (+/−) | PR status (+/−) | HER2 status (+/−) | Apocrine cytology | SRC features (≥20%) | Alveolar growth pattern | Solid growth pattern | Extracellular mucin (%) |
1 | 1.5 | Yes | 0 | 2 | 3 | 3 | 1 | No | No | + | − | − | No | Yes | No | No | 60 |
2 | 1.5 | Yes | NA | 2 | 3 | 3 | 1 | Yes | Yes | + | + | − | Yes | Yes | Yes | Yes | 70 |
3 | 3.0 | NA | 3 | 3 | 3 | 3 | 2 | No | No | + | + | + | No | No | No | No | <10 |
4 | 2.3 | No | 1 | 2 | 3 | 3 | 1 | Yes | No | + | + | + | No | No | No | No | 25 |
5 | 0.7 | Yes | 0 | 2 | 3 | 2 | 1 | Yes | No | + | + | − | No | No | No | No | 10 |
6 | 7.0 | Yes | 3 | 3 | 3 | 3 | 2 | Yes | No | + | − | − | Yes | No | Yes | Yes | <10 |
7 | 1.4 | Yes | NA | 2 | 3 | 2 | 2 | No | Yes | + | + | − | No | No | No | Yes | <10 |
8 | 7.3 | Yes | 1 | 2 | 3 | 3 | 1 | Yesc | Yes | + | − | − | No | Yes | No | No | 90 |
9 | 5.2 | No | 0 | 2 | 3 | 2 | 1 | Yes | No | + | + | − | No | No | No | No | 50 |
10 | 10.0 | No | 23 | 2 | 3 | 3 | 1 | No | No | + | + | − | No | Yes | No | Yes | 70 |
11 | 2.8 | Yes | 1 | 3 | 3 | 3 | 2 | No | No | + | + | − | No | Yes | No | No | 30 |
12 | 1.8 | Yes | 0 | 2 | 3 | 2 | 1 | No | No | + | + | − | No | No | No | No | <10 |
13 | 8.0 | Yes | 7 | 2 | 3 | 2 | 1 | No | No | + | − | − | No | Yes | No | No | 30 |
14 | 1.6 | No | 0 | 2 | 3 | 3 | 1 | Yes | No | + | − | − | No | Yes | No | No | 95 |
15 | NA | NA | NA | 2 | 3 | 2 | 1 | No | No | + | + | − | No | Yes | No | No | 10 |
16 | NA | NA | NA | 2 | 3 | 3 | 1 | No | No | + | + | − | No | Yes | No | No | 30 |
17 | NA | NA | NA | 3 | 3 | 3 | 2 | No | No | + | + | − | No | Yes | No | No | 40 |
